Nanoparticle Delivery of RIG-I Agonist Enables Effective and Safe Adjuvant Therapy in Pancreatic Cancer.

[1]  Leaf Huang,et al.  BRAF peptide vaccine facilitates therapy of murine BRAF-mutant melanoma , 2018, Cancer Immunology, Immunotherapy.

[2]  Yuhua Wang,et al.  mRNA Vaccine with Antigen-Specific Checkpoint Blockade Induces an Enhanced Immune Response against Established Melanoma. , 2017, Molecular therapy : the journal of the American Society of Gene Therapy.

[3]  P. Authié,et al.  Targeting interferon-alpha to dendritic cells enhances a CD8+ T cell response to a human CD40-targeted cancer vaccine. , 2017, Vaccine.

[4]  Xueling Wu,et al.  RIG-I and IL-6 are negative-feedback regulators of STING induced by double-stranded DNA , 2017, PloS one.

[5]  C. Caux,et al.  Pattern recognition receptors: immune targets to enhance cancer immunotherapy , 2017, Annals of oncology : official journal of the European Society for Medical Oncology.

[6]  Jinhong Jiang,et al.  Tumor-penetrating peptide enhances transcytosis of silicasome-based chemotherapy for pancreatic cancer , 2017, The Journal of clinical investigation.

[7]  Souptik Barua,et al.  Spatial computation of intratumoral T cells correlates with survival of patients with pancreatic cancer , 2017, Nature Communications.

[8]  T. Kawai,et al.  Cytosolic nucleic acid sensors and innate immune regulation , 2017, International reviews of immunology.

[9]  A. Levitzki,et al.  PSMA-homing dsRNA chimeric protein vector kills prostate cancer cells and activates anti-tumor bystander responses , 2017, Oncotarget.

[10]  William Y. Kim,et al.  Targeting Tumor-Associated Fibroblasts for Therapeutic Delivery in Desmoplastic Tumors. , 2017, Cancer research.

[11]  N. Tinari,et al.  Intratumoral Delivery of Immunotherapy—Act Locally, Think Globally , 2017, The Journal of Immunology.

[12]  Leaf Huang,et al.  Local and transient gene expression primes the liver to resist cancer metastasis , 2016, Science Translational Medicine.

[13]  Leaf Huang,et al.  Current and Future Theranostic Applications of the Lipid-Calcium-Phosphate Nanoparticle Platform , 2016, Theranostics.

[14]  K. Ishiwata,et al.  Potential applications for sigma receptor ligands in cancer diagnosis and therapy. , 2015, Biochimica et biophysica acta.

[15]  X. Ren,et al.  Regulatory B cell: New member of immunosuppressive cell club. , 2015, Human immunology.

[16]  M. Colonna,et al.  The multifaceted biology of plasmacytoid dendritic cells , 2015, Nature Reviews Immunology.

[17]  M. Menon,et al.  The expanding family of regulatory B cells , 2015, International immunology.

[18]  D. Tyler,et al.  Melanoma-Derived Wnt5a Promotes Local Dendritic-Cell Expression of IDO and Immunotolerance: Opportunities for Pharmacologic Enhancement of Immunotherapy , 2015, Cancer Immunology Research.

[19]  A. Boonstra,et al.  The role of Kupffer cells in hepatitis B and hepatitis C virus infections. , 2014, Journal of hepatology.

[20]  A. Bácsi,et al.  TLR ligands upregulate RIG‐I expression in human plasmacytoid dendritic cells in a type I IFN‐independent manner , 2014, Immunology and cell biology.

[21]  Amit Bar-Or,et al.  IL-35-producing B cells are critical regulators of immunity during autoimmune and infectious diseases , 2014, Nature.

[22]  P. Kubes,et al.  Immune surveillance by the liver , 2013, Nature Immunology.

[23]  J. Werner,et al.  Overcoming immunosuppression as a new immunotherapeutic approach against pancreatic cancer , 2013, Oncoimmunology.

[24]  P. Xie,et al.  M2-polarized tumor-associated macrophages promoted epithelial–mesenchymal transition in pancreatic cancer cells, partially through TLR4/IL-10 signaling pathway , 2013, Laboratory Investigation.

[25]  G. Tortora,et al.  Mechanisms of resistance to chemotherapeutic and anti-angiogenic drugs as novel targets for pancreatic cancer therapy , 2013, Front. Pharmacol..

[26]  G. Hartmann,et al.  Therapeutic efficacy of bifunctional siRNA combining TGF-β1 silencing with RIG-I activation in pancreatic cancer. , 2013, Cancer research.

[27]  L. Zender,et al.  T-helper-1-cell cytokines drive cancer into senescence , 2013, Nature.

[28]  K. Olive,et al.  Genetically engineered mouse models of pancreatic cancer. , 2012, Cancer journal.

[29]  R. Gibbs,et al.  Genomic sequencing of key genes in mouse pancreatic cancer cells. , 2012, Current molecular medicine.

[30]  R. Strong,et al.  The structural basis of 5' triphosphate double-stranded RNA recognition by RIG-I C-terminal domain. , 2010, Structure.

[31]  Gaurav Sahay,et al.  Endocytosis of nanomedicines. , 2010, Journal of controlled release : official journal of the Controlled Release Society.

[32]  G. Prince,et al.  Control of RSV-induced lung injury by alternatively activated macrophages is IL-4Rα-, TLR4-, and IFN-β-dependent , 2010, Mucosal Immunology.

[33]  Leaf Huang,et al.  Nanoparticles evading the reticuloendothelial system: role of the supported bilayer. , 2009, Biochimica et biophysica acta.

[34]  Yusuke Sato,et al.  Cancer Cells Expressing Toll-like Receptors and the Tumor Microenvironment , 2009, Cancer Microenvironment.

[35]  C. Berking,et al.  Proapoptotic signaling induced by RIG-I and MDA-5 results in type I interferon-independent apoptosis in human melanoma cells. , 2009, The Journal of clinical investigation.

[36]  R. Vonderheide,et al.  Immunosurveillance of pancreatic adenocarcinoma: insights from genetically engineered mouse models of cancer. , 2009, Cancer letters.

[37]  Svetlana Shulga Morskaya,et al.  5′-triphosphate-siRNA: turning gene silencing and Rig-I activation against melanoma , 2008, Nature Medicine.

[38]  M. Gale,et al.  Differential recognition of double-stranded RNA by RIG-I–like receptors in antiviral immunity , 2008, The Journal of experimental medicine.

[39]  B. Arun,et al.  Silencing of Bcl-2 expression by small interfering RNA induces autophagic cell death in MCF-7 breast cancer cells , 2008, Autophagy.

[40]  B. Williams,et al.  The response of mammalian cells to double-stranded RNA. , 2007, Cytokine & growth factor reviews.

[41]  D. Tuveson,et al.  Dynamics of the immune reaction to pancreatic cancer from inception to invasion. , 2007, Cancer research.

[42]  Kathryn Trinkaus,et al.  Selective sigma-2 ligands preferentially bind to pancreatic adenocarcinomas: applications in diagnostic imaging and therapy , 2007, Molecular Cancer.

[43]  D. Schuppan,et al.  Variants of bcl-2 specific siRNA for silencing antiapoptotic bcl-2 in pancreatic cancer , 2005, Gut.

[44]  K. Knutson,et al.  Tumor antigen-specific T helper cells in cancer immunity and immunotherapy , 2005, Cancer Immunology, Immunotherapy.